Section Arrow
Quote
NNNN.NASDAQ
- Anbio Biotechnology
Quotes are at least 15-min delayed:2025/11/14 23:07 EST
Regular Hours
Last
 26.02
+2.71 (+11.63%)
Day High 
27.69 
Prev. Close
23.31 
1-M High
31.17 
Volume 
21.61K 
Bid
24.75
Ask
27.75
Day Low
23.24 
Open
23.61 
1-M Low
10.5 
Market Cap 
1.02B 
Currency USD 
P/E 431.17 
%Yield -- 
10-SMA 18.48 
20-SMA 22.01 
50-SMA 30.7 
52-W High 55.65 
52-W Low 5.18 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.05/--
Enterprise Value
1.02B
Balance Sheet
Book Value Per Share
0.39
Cash Flow
Cash Flow Yield
0.00
Income Statement
Total Revenue
8.19M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
MLSSMilestone Scientific0.33-0.0497-13.09%-- 
AVTRAvantor11.38-0.32-2.74%11.55PE
BAXBaxter International18.47-0.23-1.23%140.32PE
HOLXHologic74.15-0.11-0.15%30.81PE
XRAYDENTSPLY SIRONA10.52-0.43-3.93%-- 
Quotes are at least 15-min delayed：2025/11/14 23:07 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.